Chimeric AAV Rep Genes for Packaging Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing recombinant adeno-associated virus (rAAV) particles lack optimization in varying rep and inverted terminal repeat (ITR) sequences, which limits the efficiency of packaging different serotypes for gene therapy applications.

Innovation Solution

The use of chimeric rep genes and ITRs from different serotypes to improve the packaging efficiency of rAAV particles, where the rep gene combines domains from multiple AAV serotypes and the ITRs are paired with a different serotype, enhancing the production of rAAV particles for various gene therapy applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional rep genes and ITRs from single serotypes are used, then the production process is simple, but the packaging efficiency of rAAV particles is limited

Engineering Contradiction:
Improvepackaging efficiencyVSAvoidrep gene structure
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The rep gene is divided into functional domains (N-terminus, DNA binding domain, helicase domain, C-terminus) that can be independently selected from different AAV serotypes. This segmentation allows optimization of each domain's function to improve packaging efficiency while maintaining manageable complexity through modular assembly.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Chimeric rep genes are constructed by combining domains from different AAV serotypes (e.g., AAV1 N-terminus with AAV2 C-terminus) to create hybrid proteins with enhanced packaging capabilities. This composite approach leverages the strengths of different serotypes to overcome the limitations of single-serotype systems.

Inventive Principle:
Principle #40Composite materials

2Productivity

If rep genes from multiple serotypes are combined, then packaging efficiency improves, but the gene structure becomes more complex

Engineering Contradiction:
ImproverAAV particle productionVSAvoidchimeric rep gene construction
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

Different domains of the rep gene are optimized with specific serotype characteristics tailored to their functional requirements. For example, the DNA binding domain may be selected from one serotype while the helicase domain is selected from another, with each selection based on the specific functional demands of that domain rather than using a uniform approach throughout the entire gene.

Inventive Principle:
Principle #3Local quality

3Adaptability or versatility

If ITRs are paired with mismatched serotypes, then packaging versatility increases, but sequence optimization becomes more difficult

Engineering Contradiction:
Improveserotype compatibilityVSAvoidITR sequence matching
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention creates rep-ITR combinations that can package multiple different serotypes of AAV particles using a single plasmid system. The chimeric rep genes are designed to recognize and function with ITRs from various serotypes, providing universal packaging capability across different AAV types without requiring separate optimized systems for each serotype combination.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12163152B2AAV chimeras
Publication Date: 2024.12.10 UNIV OF FLORIDA RESEARCH FOUNDATION INC
  • US12163152B2 patent drawing
  • US12163152B2 patent drawing
  • US12163152B2 patent drawing

AI summary

Provided herein are compositions and methods for packaging a recombinant adeno-associated virus (rAAV) particle comprising using inverted terminal repeats (ITRs) and rep genes of different serotypes and/or using chimeric rep genes.